Leishmaniose cutânea com desfecho fatal durante tratamento com antimonial pentavalente American cutaneous leishmaniasis with fatal outcome during pentavalent antimoniate treatment

Abstract

Os autores relatam o caso de paciente de 58 anos, hipertensa e diabética, com diagnóstico de leishmaniose tegumentar americana, tratada com antimoniato de N-metil-glucamina (15mg SbV/kg/dia), acompanhada pelo serviço de atenção básica em saúde e que evoluiu para óbito no 18º dia de tratamento.The authors report a case of a 58 years-old, hypertensive, diabetic female patient, with the diagnosis of American cutaneous leishmaniasis, undergoing treatment with Nmethyl glucamine antimoniate (15mg SbV/Kg/day). She was followed up by the basic health care service, but has died on the 18th treatment day.

Keywords

• Antimônio
• Atenção primária à saúde
• Leishmaniose cutânea
• Morte
• Toxicidade de drogas
• Antimony
• Death
• Drug toxicity
• Leishmaniasis, cutaneous
• Primary health care